Health Condition 1: C259- Malignant neoplasm of pancreas, unspecified Health Condition 2: C259- Malignant neoplasm of pancreas, unspecified
Conditions
Interventions
None listed
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients surgically resected for peri-ampullary tumorsof pancreatic origin, without any neoadjuvant treatment.
Exclusion criteria
Exclusion criteria: The patients who received prior treatment before surgery will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exploratory study for identification of genes mutated in Pancreatic periampullary cancer by whole exome sequencing approach to map somatic mutations, deletions and point mutations and selecting genes which are significantly alteredTimepoint: 36 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional analysis and Prediction of new therapeutic targets in pancreatic cancer to facilitate personalized approach for cancer therapy.Timepoint: 36 months | — |
Countries
India
Contacts
Public ContactDr Shailesh Vinayak Shrikhande
Tata Memorial Hospital
Outcome results
None listed